Business Details
27 Years
experience
Innovative CNS Therapies Development
Founded in 1999, Newron Pharmaceuticals is a biopharmaceutical company dedicated to advancing therapies for central and peripheral nervous system disorders. Our team of approximately 30 scientists, researchers, and clinicians leverages over 25 years of proprietary research to develop innovative treatments for conditions like Parkinsons disease and schizophrenia. Headquartered in Bresso, Italy, with a subsidiary in Morristown, NJ, we combine rigorous clinical research with strategic partnerships to deliver solutions to underserved markets.Our pipeline includes drug candidates at various clinical stages, reflecting a proven track record in development and commercialization. We prioritize transparency and timely communication with investors, ensuring alignment with global regulatory standards. Our commitment to improving patient quality of life drives every aspect of our work, from discovery to market readiness.
Services
CNS Drug Development
Clinical Trials
Pharmaceutical Research
Therapeutic Innovation
Global Partnerships
Details
- Year established: 1999
Highlights and features
- 25+ years of proprietary research in CNS disorders
- Team of 30+ experienced scientists and clinicians
- Proven track record in drug development and commercialization
- Strategic partnerships with global pharmaceutical companies
- Focused on addressing unmet needs in neurology
Services
CNS Drug Development
We specialize in developing therapies for central nervous system disorders, targeting conditions like Parkinsons disease and schizophrenia. Our approach combines cutting-edge research with clinical expertise to address gaps in patient care. By focusing on unmet medical needs, we aim to deliver innovative solutions that improve long-term outcomes for patients worldwide.
Clinical Trials
Our clinical trial programs evaluate drug candidates at all stages, ensuring rigorous assessment of safety and efficacy. With a focus on neurological disorders, we collaborate with global partners to accelerate development timelines. This process supports regulatory approvals and brings transformative treatments to market faster for patients in need.
Pharmaceutical Research
We conduct proprietary research to identify novel therapeutic targets and mechanisms for neurological diseases. Our work spans preclinical studies to late-stage development, emphasizing innovation in areas with limited existing options. This foundation drives our pipeline and supports long-term growth in the biopharma sector.
Therapeutic Innovation
Our innovation strategy prioritizes breakthrough therapies for underserved neurological conditions. By leveraging advanced technologies and scientific insights, we aim to redefine treatment paradigms. This commitment ensures patients gain access to solutions that address both current and emerging healthcare challenges.
Global Partnerships
We partner with pharmaceutical companies and research institutions to enhance drug development capabilities. These collaborations expand our reach and resources, enabling faster commercialization of therapies. By sharing expertise, we amplify our impact on global health outcomes in neurology.
People
Stefan Weber
CEO
Stefan Weber leads Newron Pharmaceuticals with over 20 years of experience in biopharmaceutical leadership. He has driven strategic growth and innovation since joining the company in 2012, focusing on CNS drug development.
Questions
What does Newron Pharmaceuticals specialize in?
We focus on developing therapies for central and peripheral nervous system disorders, including Parkinson’s disease and schizophrenia.
Where is Newron Pharmaceuticals headquartered?
Our headquarters are in Bresso, Italy, with a subsidiary in Morristown, NJ, USA.
How long has Newron Pharmaceuticals been in business?
We were founded in 1999 and have over 25 years of experience in neurological drug development.
What clinical trials does Newron Pharmaceuticals conduct?
We run trials for drug candidates targeting unmet needs in neurology, spanning all clinical stages.
Does Newron Pharmaceuticals work with other pharmaceutical companies?
Yes, we collaborate globally to advance our pipeline and commercialize innovative therapies.
How can investors access Newron Pharmaceuticals's financial data?
Financial reports and shareholder information are available on our Investor Relations website.
